Introduction
Apoptosis (programmed cell death) is the genetically controlled ablation of cells during normal development. Apoptosis is distinct from necrosis in both the biochemical and the morphological changes that occur. In contrast to necrotic cells, apoptotic cells are characterized morphologically by compaction of the nuclear chromatin, shrinkage of the cytoplasm and production of membrane-bound apoptotic bodies. Biochemically, apoptosis is distinguished by fragmentation of the genome and cleavage or degradation of several cellular proteins. Several approaches have been developed to study apoptosis. Cell death cascades are complex and dynamic, underscoring the importance of a multi-parametric approach for accurate assessment (Figure 1).
ABP Biosciences offers a wide array of apoptosis assays for measuring multiple components on a choice of assay platforms:
-
Annexin V binding assays
-
Caspase activity assays
-
Mitochondrial membrane potential assays
-
DNA fragmentation and morphology
|
|
Annexin V Binding Assays
Our annexin V conjugates and kits provide quick and reliable detection methods for studying the externalization of phosphatidylserine in apoptotic cells.
|
|
Caspase Activity Assays
A distinctive feature of the early stage apoptosis is the activation of caspase enzymes. ABP Biosciences offers a wide array of caspase assays in live and dead cells.
|
|
Mitochondrial Membrane Potential Assays
A distinctive feature of the early stage apoptosis of programmed cell death is the disruption of active mitochondria. These changes can be monitored using our extensive selection of potential-sensitive mitochondrial stains.
|
|
DNA Fragmentation and Morphology
A distinctive feature of the late stage apoptosis is the DNA fragmentation and nuclear changes. Our TUNEL assays provide quick and reliable detection methods for studying in situ apoptotic DNA fragmentation.
|
|
Figure 1. Cell Apoptosis Pathway
|
Related Products
Related Products